Home » Watson’s Former HQ Gets 483 for Deviation Investigation Shortfalls
Watson’s Former HQ Gets 483 for Deviation Investigation Shortfalls
Watson Laboratories, now known as Actavis, received a Form 483 for deviation investigation shortfalls at a facility located on the site of the company’s former Corona, Calif., headquarters.
Drug GMP Report
Drug GMP Report
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May